Protein Purification and Isolation Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Consumables), By Technology, By Application, By End Use, By Region – Market Forecast, 2025–2034

The protein purification and isolation market size is expected to reach USD 28.47 billion by 2034, according to a new study by Polaris Market Research. The report “Protein Purification and Isolation Market Share, Size, Trends, Industry Analysis Report By Product (Instruments, Consumables), By Technology, By Application, By End Use, By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Protein purification and isolation are critical preparatory processes used to obtain functionally active and highly purified proteins from complex biological mixtures. This market is driven by the rapid advancements in purification technologies, which are enhancing the precision, speed, and scalability of protein separation. There is a growing need for methods that can deliver high-yield and contamination-free outputs as research becomes increasingly focused on protein structure and function. Integration of automation, miniaturization, and high-throughput screening streamlines workflows, making these technologies more efficient and accessible for diverse end users in life sciences and drug discovery.

The protein purification and isolation market is further driven by the rising demand for protein-based therapeutics across multiple disease areas. The growing focus on biologics, such as monoclonal antibodies, vaccines, and enzymes, has increased the need for robust and reproducible purification techniques. This trend is further supported by ongoing efforts in therapeutic development, requiring consistent and scalable production of high-purity proteins. Therefore, as biologics continue to gain traction in the pharmaceutical pipeline, the importance of efficient protein purification tools boosts, reinforcing the market’s sustained growth.

Protein Purification and Isolation Market Report Highlights

In terms of product, the consumables segment dominated the market in 2024, due to recurring use and versatility across purification workflows. Their essential role in daily operations sustained market leadership.

Based on technology, the electrophoresis segment is projected for robust expansion, due to precise protein analysis. Its accuracy in assessing molecular properties drives adoption in research and quality control.

North America held 37.1% global share in 2024 due to advanced infrastructure, strong presence of biotech/pharma companies, and high adoption of technological advancements.

The market in Asia Pacific is expected to witness the fastest growth with a 12.87% CAGR during 2025–2034 due to the research investments that boost biopharma production and favorable policies that accelerate the development.

A few global key players in the protein purification and isolation market include Abcam Limited; Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Danaher Corporation (Cytiva); Merck KGaA; Promega Corporation; QIAGEN; Revvity; Sartorius AG; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the protein purification and isolation market report on the basis of product, technology, application, end use, and region:

By Product Outlook (Revenue, USD Billion, 2020–2034)

Instruments

Consumables

Kits

Reagents

Columns

Magnetic Beads

Resins

Others

By Technology Outlook (Revenue, USD Billion, 2020–2034)

Ultrafiltration

Precipitation

Chromatography

Ion Exchange Chromatography

Affinity Chromatography

Reversed Phase Chromatography

Size Exclusion Chromatography

Hydrophobic Interaction Chromatography

Electrophoresis

Gel Electrophoresis

Isoelectric Focusing

Capillary Electrophoresis

Western Blotting

Others

By Application Outlook (Revenue, USD Billion, 2020–2034)

Drug Screening

Biomarker Discovery

Protein-Protein Interaction Studies

Diagnostics

By End Use Outlook (Revenue, USD Billion, 2020–2034)

Academic and Research Institutes

Hospitals

Pharmaceutical and Biotechnology Companies

CROs

By Regional Outlook (Revenue, USD Billion, 2020–2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa Show more